Immunosuppressive TNF alfa inhibitors Infliximab s.c. administration II. (hereinafter also referred to as "contract" or "PR")
Imunosupresiva inhibitory TNF alfa Infliximab s.c. podání II. (dále také jen “zakázka” nebo „VZ“)
Czechia · Praha
Contract
BuyerInstitut klinické a experimentální medicíny
TypeSupplies
Estimated value71.500.000 €
Published13 August 2026
CategoryMedical equipment & pharma · CPV 33652300
Who has won here before
| Company | Awards | Period |
|---|---|---|
| PHOENIX lékárenský velkoobchod, s.r.o. | 38 | 2022–2026 |
| Alliance Healthcare s.r.o. | 30 | 2015–2026 |
| PHARMOS, a.s. | 29 | 2022–2026 |
| PROMEDICA PRAHA GROUP, a.s. | 27 | 2022–2026 |
| CARDION s.r.o. | 17 | 2015–2026 |
From 13.7M documented awards · regular winners know this buyer's requirements — that is your competition.
How often this buyer tenders this
20212
202287
2024288
2025385
2026231
Who knows the rhythm prepares instead of reacting.
22
days until the deadline — Friday 11 September at 00:00
How to bid
Read the full notice — Original + documents
Goes directly to this tender on TED — Tenders Electronic Daily. The full specification and all annexes are there.
Tenders like this, every morning at 7:30 in your inbox.
Start free →